Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver disease
Phase 2
- Conditions
- Thrombocytopenic patients with chronic liver disease
- Registration Number
- JPRN-jRCT2080221585
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Thrombocytopenic patients with chronic liver disease undergoing percutaneous ablation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method